FormWeb • lenalidomide

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Add Formweb to your mobile device

Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

lenalidomide

lenalidomide

Non-formulary Non-stocked, Not-Ordered drugs

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Revlimid	CAPSULE, ORAL	5 mg, 10 mg

Comments:

Revlimid medication guide

Thalidomide derivative indicated for the treatment of transfusion-dependent anemia in patients with specific types of myelodysplastic syndrome. It is only available through a special registry program called Rev-Assist, where the drug is directly sent to the patient. The hospital may not obtain the drug, patients would have to use their own supply.

Reviewed: February 28, 2006

REMS (Revlimid): View FDA REMS Info

Last updated: Jun. 28, 2022

Black Box Warning: Embryo-Fetal Toxicity and Restricted Distribution Program, Hematologic Toxicity, Venous Thromboembolism
HAZ-MED: Group 2
Chemotherapy:

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.